What one share of Cardiff Lexington holds
Our company is a targeted healthcare holding company dedicated to acquiring and building middle-market niche healthcare clinics, primarily in orthopedics, spine care, and pain management.
Cardiff Lexington’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.78 |
|---|---|
| Profit | −$0.80 |
| Dividends | $0.00 |
| Cash and investments | $0.01 |
| Debt | $1.49 |
| Book value | $0.11 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | $11.10 | −$31.22 | $4.25 | −$9.72 | — | −$24.12 |
| 2024 | $2.17 | −$1.12 | — | — | — | $0.53 |
| 2025 | $1.36 | −$0.77 | — | — | — | −$0.18 |
Common questions about Cardiff Lexington
How much does one share of Cardiff Lexington earn?
Over the last 12 months, Cardiff Lexington lost $0.80 for each share on $0.78 of sales.
Does Cardiff Lexington pay a dividend?
Cardiff Lexington didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Cardiff Lexington’s book value per share?
Cardiff Lexington’s book value is $0.11 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Cardiff Lexington have?
Each share of Cardiff Lexington has $0.01 of cash and investments and $1.49 of debt, as of June 30, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.